Colin Shane Brooks

Background

About Colin Shane Brooks

Purposeful Director of Quality Management Systems (QMS), Operational Excellence, and Portfolio, Program, and Project Management (PPM) with over 15 years of leadership experience in biotechnology, biopharmaceuticals, life sciences, cell and gene therapy, and medical devices within regulated environments. A transformational leader with a proven ability to drive Operational Excellence (OpEx), lead large-scale initiatives, and optimize compliance across federal, academic, and private sectors. Expert in Chemistry, Manufacturing, and Controls (CMC), QMS, OPEX, and Program Management Office (PMO), ensuring adherence to critical regulations, including Code of Federal Regulations (CFR), International Organization for Standardization (ISO), International Council for Harmonization (ICH), Good Laboratory Practices (GxP), Good Manufacturing Practices (GMP), European Medicines Agency (EMA), and World Health Organization (WHO). Proven success in regulatory compliance across all stages, from product development and manufacturing within GxP-regulated environments to commercialization and post-commercialization, ensuring seamless execution and strategic impact. Recognized for leading global, remote, and cross-functional teams to align business objectives with measurable results, fostering a culture of inclusion, continuous improvement, and innovation. Adept at executing enterprise-wide transformations, regulatory initiatives, and Lean methodologies to enhance speed-to-market, cost efficiency, and operational effectiveness. Enthusiastic about driving change, optimizing processes, and leveraging data-driven decision-making to propel organizations forward.